Literature DB >> 23812036

RNase non-sensitive and endocytosis independent siRNA delivery system: delivery of siRNA into tumor cells and high efficiency induction of apoptosis.

Xinglu Jiang1, Guobao Wang, Ru Liu, Yaling Wang, Yongkui Wang, Xiaozhong Qiu, Xueyun Gao.   

Abstract

To date, RNase degradation and endosome/lysosome trapping are still serious problems for siRNA-based molecular therapy, although different kinds of delivery formulations have been tried. In this report, a cell penetrating peptide (CPP, including a positively charged segment, a linear segment, and a hydrophobic segment) and a single wall carbon nanotube (SWCNT) are applied together by a simple method to act as a siRNA delivery system. The siRNAs first form a complex with the positively charged segment of CPP via electrostatic forces, and the siRNA-CPP further coats the surface of the SWCNT via hydrophobic interactions. This siRNA delivery system is non-sensitive to RNase and can avoid endosome/lysosome trapping in vitro. When this siRNA delivery system is studied in Hela cells, siRNA uptake was observed in 98% Hela cells, and over 70% mRNA of mammalian target of rapamycin (mTOR) is knocked down, triggering cell apoptosis on a significant scale. Our siRNA delivery system is easy to handle and benign to cultured cells, providing a very efficient approach for the delivery of siRNA into the cell cytosol and cleaving the target mRNA therein.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23812036     DOI: 10.1039/c3nr01183f

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  3 in total

Review 1.  The Landscape of lncRNAs in Multiple Myeloma: Implications in the "Hallmarks of Cancer", Clinical Perspectives and Therapeutic Opportunities.

Authors:  Ilaria Saltarella; Benedetta Apollonio; Aurelia Lamanuzzi; Vanessa Desantis; Maria Addolorata Mariggiò; Jean-François Desaphy; Angelo Vacca; Maria Antonia Frassanito
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

2.  Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.

Authors:  Yi Hu; Jianhong Lin; Hua Fang; Jing Fang; Chen Li; Wei Chen; Shuang Liu; Sarah Ondrejka; Zihua Gong; Frederic Reu; Jaroslaw Maciejewski; Qing Yi; Jian-Jun Zhao
Journal:  Leukemia       Date:  2018-03-22       Impact factor: 11.528

3.  In situ tumor-triggered subcellular precise delivery of multi-drugs for enhanced chemo-photothermal-starvation combination antitumor therapy.

Authors:  Xinglu Jiang; Xiaobo Fan; Rui Zhang; Wei Xu; Hailu Wu; Fengfeng Zhao; Han Xiao; Chen Zhang; Chenggui Zhao; Guoqiu Wu
Journal:  Theranostics       Date:  2020-10-27       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.